Microglia-derived galectin-3 in neuroinflammation; a bittersweet ligand?

Area of Science:

• Neuroimmunology
• Molecular Biology
• Drug Discovery

Background:

• Galectins are conserved β-galactoside-binding proteins involved in innate immunity.
• Galectin-3 plays a significant role in modulating brain immune responses and microglial activation.
• Its dual role in neuroinflammation presents a complex challenge for therapeutic targeting.

Purpose of the Study:

• To provide an updated and balanced discussion on the multifaceted roles of galectin-3 in neuroinflammation.
• To explore galectin-3's potential as a therapeutic target for neurodegenerative diseases.
• To highlight the importance of understanding galectin-3's structure and physiology for drug development.

Main Methods:

• Review of experimental studies on galectin-3 in neuroinflammatory diseases.
• Analysis of galectin-3's involvement in innate immune responses in the brain.
• Discussion of galectin-3's structure-function relationship and its impact on neuroprotection.

Main Results:

• Galectin-3 acts as a double-edged sword, demonstrating both beneficial and detrimental effects in neuroinflammatory contexts.
• Its activity is context-dependent, influencing macrophage and microglial functions.
• Experimental evidence supports both protective and deleterious roles of galectin-3 in various neurological disorders.

Conclusions:

• Galectin-3 is a critical endogenous immune modulator in the brain with significant implications for neurodegenerative diseases.
• Targeting galectin-3 offers potential for developing novel therapeutics for conditions like Alzheimer's, Parkinson's, and Huntington's disease.
• Further research into galectin-3's precise mechanisms and structure is crucial for designing effective neuroprotective agents.